Featured Transactions

We have been made aware of bad actors holding themselves out as Jefferies representatives targeting India residents.

Examples include an advertisement in The Times of India’s 8 March 2024 edition in the name of “JFR Investment Technology Group” claiming to be a subsidiary of Jefferies Financial Group Inc., as well as groups offering investment advice and soliciting money from individuals in the name of Jefferies on social media platforms. Please note that Jefferies does not accept deposits from or offer financial services to retail investors or individuals in India. Jefferies does not contact customers over social media platforms such as Telegram, WhatsApp or from free email accounts such as Yahoo or Gmail, and any contact with Jefferies will come from an “@jefferies.com” email address and/or be found on the www.jefferies.com website. If you think you or someone you know has been a victim of fraud, please report the matter to the police or other relevant authorities.

Please refer to the following additional notices:

M&A

Consumer

Aug-2024
Pending

$1,464,000,000

Sale to Bansk Group

Sole Financial Advisor
Healthcare

Jul-2024
Pending

₹13,630,000,000

Sale to Mankind Pharma

Joint Financial Advisor
Energy

Jul-2024
Pending

$5,000,000,000

Sale of Williston Basin business
to Devon Energy

Sole Financial Advisor
AeroDefense

Jun-2024

$1,290,000,000

Sale to Cognizant

Lead Financial Advisor
Media

April-2024

£1,584,000,000

Acquisition of Hipgnosis Songs
Fund Limited

Sole Financial Advisor
Energy

May-2024

$3,250,000,000

Sale to Energy Transfer L.P.

Sole Financial Advisor
Technology

Apr-2024

$5,315,000,000

Sale to Thoma Bravo, L.P.

Joint Financial Advisor
Industrials

Mar-2024

$18,250,000,000

Sale to The Home Depot

Lead Financial Advisor
Energy

Feb-2024

$26,000,000,000

Merger with Endeavor Resources, L.P.

Lead Financial Advisor

Equity

Healthcare

May-2024

$555,000,000

Private Placement of Equity

Sole Placement Agent
AeroDefense

Apr-2024

$354,000,000

Initial Public Offering

Lead Left Bookrunner
Finance

Mar-2024

$1,050,000,000

Private Placement of Equity

Sole Financial Advisor and
Sole Placement Agent
Technology

Mar-2024

$700,000,000

Private Placement of Equity

Placement Agent
Healthcare

Jan-2024

$863,000,000

Common Stock Offering

Joint Bookrunner
Healthcare

Jul-2023

$345,000,000

Initial Public Offering

Lead Left Bookrunner
Consumer

Jun-2023

$365,000,000

Initial Public Offering

Joint Lead Bookrunner
Consumer

Jun-2023

$461,000,000

Initial Public Offering

Joint Lead Bookrunner
Healthcare

May-2023

$621,000,000

Initial Public Offering

Joint Bookrunner

Debt

Technology

Jun-2023

$1,050,000,000

Credit Facility

Joint Lead Arranger
Healthcare

May-2023

$1,383,000,000

Amendment and Extension of Credit Facility

Joint Lead Arranger
Healthcare

May-2023

$1,060,000,000

Credit Facility

Joint Lead Arranger
Finance

Feb-2023

$1,170,000,000

Credit Facility

Joint Lead Arranger
Consumer

Feb-2023

$1,132,000,000

Amendment and Extension of Credit Facility

Joint Lead Arranger
Technology

Nov-2022

$3,496,000,000

Credit Facility to Finance Acquisition of Intertrust N.V.

Joint Lead Arranger
Technology

Aug-2022

$1,720,000,000

Credit Facility to Finance Acquisition by KKR

Joint Lead Arranger
Power

May-2022

$1,543,000,000

Credit Facility

Sole Lead Arranger
Industrials

Apr-2022

$3,526,000,000

Financing for Acquisition of Ferro Corp. and merger with Chromaflo

Joint Lead Arranger and Joint Bookrunner

Restructuring

AeroDefense

Aug-2024

$3,400,000,000

Reorganization

Financial Advisor to the Official Committee
of Unsecured Creditors
Healthcare

Aug-2024

$4,000,000,000

Reorganization

Financial Advisor to the Official Committee
of Tort Claimants
Industrials

May-2024

$1,059,000,000

Restructuring

Financial Advisor to the Official Committee
of Unsecured Creditors
Healthcare

Apr-2024

$8,148,000,000

Restructuring

Financial Advisor to the Official Committee
of Opioid Claimants
Healthcare

Sep-2023

$660,000,000

Restructuring

Financial Advisor to the Company
Healthcare

Jul-2023

$618,000,000

Restructuring

Financial Advisor to the Official Committee
of Unsecured Creditors
Finance

May-2023

$832,000,000

Restructuring

Financial Advisor to the Company
Consumer

Apr-2023

$769,000,000

Restructuring

Financial Advisor to the Company
Healthcare

Jun-2022

$5,293,000,000

Restructuring

Financial Advisor to the Official Committee
of Opioid Related Claims

Back to Investment Banking overview